戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 rylation of Akt and FoxO1 following systemic insulin injection.
2 re of blood glucose levels to decrease after insulin injection.
3 ose fell to <60 mg/dl after a jugular venous insulin injection.
4 ency which developed between 5 and 8 h after insulin injection.
5 l mice) and abnormal glucose clearance after insulin injection.
6 sulin plus a bedtime subcutaneous ultralente insulin injection.
7  insulin-derived amyloidosis at the sites of insulin injection.
8 female) or opposite adjustments (male) after insulin injection.
9      Type I diabetics are dependent on daily insulin injections.
10  type 1 diabetes treated with multiple daily insulin injections.
11 n pump therapy or with multiple (>/=4) daily insulin injections.
12 ubled with placebo and further elevated with insulin injections.
13 sive alternative to conventional preprandial insulin injections.
14 n be extended, thereby delaying the need for insulin injections.
15 ients treated with conventional subcutaneous insulin injections.
16  in adults with type 1 diabetes treated with insulin injections.
17 tes treated with oral diabetes medication or insulin injections.
18 5% (58 mmol/mol) treated with multiple daily insulin injections.
19 s within 2% of that observed with peripheral insulin injection (1,820 +/- 711 vs. 1,791 +/- 661 micro
20 tu contraction, and 15 min following maximal insulin injection (16.6 units/kg of body weight).
21 its exogenous tyrosine kinase activity after insulin injection (64%; p < 0.01 and 96% and p < 0.001,
22 -stage T2DM conditions that require repeated insulin injection and can potentially minimize the occur
23 e, time course experiments on the effects of insulin injection and treadmill running exercise were pe
24 millions of patients have relied on frequent insulin injections and glucose monitoring to combat the
25 ype 1 diabetes who were using multiple daily insulin injections and had hemoglobin A1c (HbA1c) levels
26 functional B-cell mass in diabetic patients, insulin injections and the use of insulin pumps are most
27 ing either an insulin pump or multiple daily insulin injections, and glycated haemoglobin (HbA(1c)) l
28 afish recovered rapidly without the need for insulin injections, and normoglycemia was attained withi
29 reated diabetic subjects used multiple daily insulin injections; and 40% of patients with insulin-dep
30  diabetic rats were treated with twice-daily insulin injections, basal hepatic insulin production, or
31 protocol for intravenous glucose loading and insulin injection before administration of (18)F-FDG for
32 or-bound insulin in endosomes at 2 min after insulin injection by 93% as determined by exclusion from
33 tatrophin treatment could augment or replace insulin injections by increasing the number of endogenou
34                                              Insulin injection caused a similar reduction of circulat
35    Unlike the saline group, each incremental insulin injection caused interstitial (lymph) insulin to
36 abetes mellitus usually requires two or more insulin injections daily.
37      Standard insulin therapy was one or two insulin injections daily.
38                                        Brain insulin injections decrease the magnitude of the reflexi
39 and undesirable side-effects associated with insulin injection demand novel drugs for the diseases.
40 rvet monkeys receiving twice-daily exogenous insulin injections for 8-20 weeks.
41 ticipate a future without the need for daily insulin injections for children with T1D.
42 lt, acutely diabetic NOD mice do not require insulin injections for survival for a significant time p
43 entage of adults who received multiple daily insulin injections for type 2 diabetes used CGM on a dai
44 n analogues) per year for a once-daily basal insulin injection (for type 2 diabetes), including the c
45 iving no insulin injections, those receiving insulin injections had a dose-response increase in the o
46  control of hypoglycemic seizures induced by insulin injection in fasted and nonfasted rats.
47                    We hypothesize that brain insulin injection in T2DM rats attenuates the augmented
48 on has led to sulfonylurea therapy replacing insulin injections in many patients.
49 ylurea treatment of HNF1A/HNF4A-diabetes vs. insulin injections in type 1 diabetes).
50 orphic PDK1 mice are viable and fertile, and insulin injection induces the normal activation of PKB,
51 py) with that of a regimen of multiple daily insulin injections (injection therapy) in 485 patients (
52  insulin receptor content of endosomes after insulin injection (integrated over 0-45 min) by 31% when
53                The results demonstrated that insulin injections into the brain normalized the augment
54 ted to the loss of the anorectic response to insulin injections into the central nucleus of the amygd
55 regimen for type 1 diabetes with twice-daily insulin injections is effective in preventing postprandi
56 ments in glycaemic control, with fewer basal insulin injections, lower bolus insulin dose, and with n
57  (Rx) of either IP (n = 9) or multiple daily insulin injections (MDI; n = 13).
58  (median duration, 3.7 years) and 16460 used insulin injections (median duration, 3.6 years).
59 t that a reduction in the frequency of basal insulin injections might facilitate treatment acceptance
60                             However, neither insulin injection nor insulin receptor deficiency result
61                                        Basal insulin injection of mice increased GLUT-1 expression an
62 e obtained from mice 10, 15, or 30 min after insulin injection or immediately after strenuous treadmi
63 scale and therapeutic effect of subcutaneous insulin injection or infusion.
64                                Despite daily insulin injections, patients typically develop cardiovas
65                           The mean number of insulin injections per day increased from 2.2 to 2.5 acr
66 icant lifestyle adjustments, including daily insulin injections, regular glucose monitoring, and diet
67                                              Insulin injection resulted in normal tyrosyl phosphoryla
68                         Strikingly, a single insulin injection reversed the deleterious effects of HF
69                 However, we found that daily insulin injections significantly increased weight gain i
70 ad the lowest insulin levels 75 min after an insulin injection, suggesting an altered rate of insulin
71 dministration requires frequent subcutaneous insulin injections that are associated with poor patient
72 ally accurate when it was assumed that after insulin injection the glycemia in the subcutaneous fluid
73 te of decline exceeded 1.8 mg/(dl.min) after insulin injection, the subcutaneous glucose concentratio
74 with type 1 diabetes who used multiple daily insulin injections, the use of CGM compared with usual c
75  type 1 diabetes treated with multiple daily insulin injections, the use of continuous glucose monito
76 ely move type 1 diabetes treatment away from insulin injection therapy and toward a cure.
77 ower with insulin pump therapy compared with insulin injection therapy in children, adolescents, and
78 iabetes, insulin pump therapy, compared with insulin injection therapy, was associated with lower ris
79 red with patients with diabetes receiving no insulin injections, those receiving insulin injections h
80 concentration between 6 and 20 min after the insulin injection was different for subcutaneous tissue
81                    Until recently, life-long insulin injection was the only approved treatment for T1
82 ea under the insulin curves after the portal insulin injection was within 2% of that observed with pe
83 et of experiments, a control "zero" dose (no insulin injection) was also performed.
84                                        Daily insulin injections were given to four groups of rats and
85 cutaneous insulin infusion or multiple daily insulin injections with or without CGM) or the intervent